July 17 Company Quick Takes: FDA approves Merck antibiotic combo; plus PureTech, Inovio, BiomX

FDA approves Merck's antibiotic combo
FDA approved Merck's Recarbrio imipenem/cilastatin/relebactam antibacterial to treat adults with complicated urinary tract infections (cUTIs) and complicated intra-abdominal infections (cIAIs). Unlike most of its peers,

Read the full 292 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE